SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-048172
Filing Date
2020-10-28
Accepted
2020-10-28 08:31:36
Documents
12
Period of Report
2020-10-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K - LONGBOARD PHARMACEUTICALS arna-8k_20201027.htm   iXBRL 8-K 48306
  Complete submission text file 0001564590-20-048172.txt   176622

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA arna-20201027.xsd EX-101.SCH 5784
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20201027_lab.xml EX-101.LAB 18706
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20201027_pre.xml EX-101.PRE 11179
5 EXTRACTED XBRL INSTANCE DOCUMENT arna-8k_20201027_htm.xml XML 3430
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31161 | Film No.: 201266295
SIC: 2834 Pharmaceutical Preparations